GREATER CHINA
Double Patenting: A multi-jurisdictional minefield | China, Hong Kong & Southeast Asia
“In China, there is no doctrine preventing an applicant from obtaining multiple patents for obvious variants, patentably indistinct subject matter, or incremental improvements, so long as the claims are...
“In China, there is no doctrine preventing an applicant from obtaining multiple patents for obvious variants, patentably indistinct subject...
Read More
GREATER CHINA
China | Amendments to Patent Examination Guidelines finalised
After six months of drafting and revisions, the China National Intellectual Property Administration (CNIPA) issued the finalised version of the Guidelines for Patent Examination on 13 November 2025. These revisions will...
After six months of drafting and revisions, the China National Intellectual Property Administration (CNIPA) issued the finalised version of...
Read More
GREATER CHINA
How divisional patent applications work in China
Chinese divisional practice is known for its unique timing requirements, prerequisites for filing a divisional, and strict procedural deadlines. For patent holders looking to secure their rights in China,...
Chinese divisional practice is known for its unique timing requirements, prerequisites for filing a divisional, and strict procedural deadlines....
Read More
GREATER CHINA
China | Good faith principle for patent applications
The principle of ‘good faith’ plays a crucial role in ensuring the integrity and reliability of patent applications. This principle is particularly emphasised in China's patent law, where adherence...
The principle of ‘good faith’ plays a crucial role in ensuring the integrity and reliability of patent applications. This...
Read More
GREATER CHINA
Pharmaceutical Patent disputes in China | The nuances of “offer to sell”
The application of Bolar exceptions and the definition of "offer to sell" have long been contentious issues in the pharmaceutical industry in China. Article 11 of the Chinese Patent Law...
The application of Bolar exceptions and the definition of "offer to sell" have long been contentious issues in the pharmaceutical...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe